Progenitor cell therapy in patients with critical limb ischemia without surgical options.
about
Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical EfficacyAlways contact a vascular interventional specialist before amputating a patient with critical limb ischemiaStem cell trials for cardiovascular medicine: ethical rationale.Toward a mouse model of hind limb ischemia to test therapeutic angiogenesisA phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study.Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.Stem cell therapy for critical limb ischaemia - a review.Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia modelAllogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.Insights into mechanisms behind arteriogenesis: what does the future hold?Review article: endothelial progenitor cells in renal diseaseImprovement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.Therapeutic angiogenesis for the management of refractory angina: current concepts.Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.Intra-arterial autologous bone marrow cell transplantation in a patient with upper-extremity critical limb ischemia.Role of serum levels of angiogenic cytokines in assessment of angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia.Impact of angiogenic therapy in the treatment of critical lower limb ischemia in an animal model.Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
P2860
Q33722293-D53059AF-1238-4CB9-A08D-CB8D3F974768Q33843965-569CFB83-F59B-4882-900D-68054121C2E5Q34331206-ED45592D-9AF7-4576-9FF0-9448672DDC33Q34353144-FF2C7161-C36A-4C10-9F92-EBA29234348CQ34496411-D3C972FE-C1A3-45FF-AD4C-59A3A8720BFDQ36014060-D65BF3BB-E01E-4C1B-BED1-1C2411ABBC5CQ36262074-F803A209-0C35-4556-912A-D40E2DEA28A2Q36428933-49A44FD3-6B04-4670-9070-02D1EBF1517FQ36472391-6FC0C836-4A34-4F3C-8FF0-C7C2BD2EB70FQ36870189-E81B4F3D-82C9-4CB3-9325-ADC90923DCA8Q36923569-B6BD66EC-964E-4FB8-B6BB-5F1C8BEBC67AQ36944312-ADB7D623-55C0-49BD-BA31-ABB1D32513ACQ37234751-FB410A33-50F7-4E2E-A1F6-F50D9F2CA0B7Q37322166-B65C3BED-A4CD-4689-8999-201622E3E198Q37510919-F968D72F-CCFB-451E-B51F-F72552B52357Q37734560-24E79F28-190E-49F9-AFFE-D134A8D0E3FEQ38100692-3060D01E-F353-4A7E-B2A2-67212D8C5455Q40035321-6ED3D0E5-7CEF-4C14-B6AC-13E906981920Q45731764-D78C9F1A-7383-42A6-8EDC-C9BEE36EDA29Q45861381-33B5ECC3-E35E-4F64-8DFC-13CFCA9949F1Q45868651-C672C8EB-AAB8-47A2-9E75-8A363E91229C
P2860
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@en
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@nl
type
label
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@en
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@nl
prefLabel
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@en
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@nl
P2093
P1433
P1476
Progenitor cell therapy in patients with critical limb ischemia without surgical options.
@en
P2093
Daniel J Lips
Frans L Moll
Ralf W Sprengers
P304
P356
10.1097/SLA.0B013E318153FDCB
P407
P577
2008-03-01T00:00:00Z